CVEvulnerability

CVE-2026-94033

2.0 LOW Published 2026-09-20 Modified 2026-09-21 Official page ↗
Status
Deferred
Published
2026-09-20
Last modified
2026-09-21
Assigner
[email protected]
CVSS 4.0 ([email protected])
2.0 LOW — CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
CVSS 3.1 ([email protected])
3.5 LOW — CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:N/I:L/A:N
CVSS 2.0 ([email protected])
4.0 MEDIUM — AV:N/AC:L/Au:S/C:N/I:P/A:N
Weaknesses
CWE-79, CWE-94

Description

A vulnerability has been found in SourceCodester Drug Recommendation System 1.0. This vulnerability affects unknown code of the file /drug_recommender/Admin/add_user of the component User Management. Such manipulation of the argument txtname/txtemail/txtpassword leads to cross site scripting. It is possible to launch the attack remotely. The exploit has been disclosed to the public and may be used.

Related

Weakness · CWE (2)

  • CWE-79 Improper Neutralization of Input During Web Page Generation weakness
  • CWE-94 Improper Control of Generation of Code weakness

References